Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Importation May Be Price For Moving McClellan To CMS

This article was originally published in The Pink Sheet Daily

Executive Summary

Reimportation advocates are threatening to put a hold on the nomination of FDA Commissioner McClellan to head CMS. HHS' reimportation task force may be one part of a compromise.

You may also be interested in...



CMS Nominee McClellan Says He Will Testify On Rx Imports, But May Still Face Confirmation Delay

FDA Commissioner McClellan tells the Senate Finance Committee he will testify about drug reimportation after his nomination to head the Centers for Medicare & Medicaid Services is approved by the Senate. Sen. Dorgan, who has threatened to place a "hold" on the vote, is understood to be unwilling to wait.

CMS Nominee McClellan Says He Will Testify On Rx Imports, But May Still Face Confirmation Delay

FDA Commissioner McClellan tells the Senate Finance Committee he will testify about drug reimportation after his nomination to head the Centers for Medicare & Medicaid Services is approved by the Senate. Sen. Dorgan, who has threatened to place a "hold" on the vote, is understood to be unwilling to wait.

Reimportation Amendment Added To Senate FY 2005 Budget Resolution

Sen. Stabenow's amendment passes Budget Committee 14-8 with five GOP votes, including Grassley and Gregg. U.S. consumers would save $40 bil. over 10 years.

Related Content

Topics

UsernamePublicRestriction

Register

ID1131849

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel